VJOncology is committed to improving our service to you

ASCO 2019 | The AVANOVA study: niraparib and bevacizumab for ovarian cancer

VJOncology is committed to improving our service to you

Mansoor Raza Mirza

In this video, Mansoor Raza Mirza, MD, of the Copenhagen University Hospital, Copenhagen, Denmark, discusses the AVANOVA study (NCT02354131) of niraparib and bevacizumab for treating ovarian cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter